• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SYT16 是胶质母细胞瘤的预后生物标志物,并与免疫浸润相关:基于 TCGA 数据的研究。

SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.

机构信息

Department of Spine, Wuxi Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi 214000, PR China.

Department of Clinical Biobank, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, PR China; Nantong University Xinling College, Nantong, Jiangsu 226001, PR China.

出版信息

Int Immunopharmacol. 2020 Jul;84:106490. doi: 10.1016/j.intimp.2020.106490. Epub 2020 Apr 11.

DOI:10.1016/j.intimp.2020.106490
PMID:32289666
Abstract

BACKGROUND

Glioma is the most lethal primary brain tumor. Lower-grade glioma (LGG) is the crucial pathological type of Glioma. Immune-infiltration of the tumor microenvironment positively associated with overall survival in LGG. SYT16 is a gene has not been reported in cancer. We assess the role of SYT16 in LGG, via the publicly available TCGA database.

METHODS

Gene Expression Profiling Interactive Analysis (GEPIA) was used to analyze the expression of SYT16 in LGG. We evaluated the influence of SYT16 on survival of LGG patients by survival module. Then, datasets of LGG were downloaded from TCGA. The correlations between the clinical information and SYT16 expression were analyzed using logistic regression. Univariable survival and Multivariate Cox analysis was used to compare several clinical characteristics with survival. we also explore the correlation between SYT16 and cancer immune infiltrates using CIBERSORT and correlation module of GEPIA. Gene set enrichment analysis (GSEA) was performed using the TCGA dataset. In addition, we use TIMER to explore the collection of SYT16 Expression and Immune Infiltration Level in LGG and to explore cumulative survival in LGG.

RESULTS

The univariate analysis using logistic regression, indicated that increased SYT16 expression significantly correlated with the tumor grade. Moreover, multivariate analysis revealed that the up-regulated SYT16 expression is an independent prognostic factor for good prognosis. Specifically, SYT16 expression level has significant negative correlations with infiltrating levels of B cell, CD4+ T cells, Macrophages, Neutrophils and DCs in LGG. In addition, GSEA identified ingle organism behavior, gated channel activity, cognition, transporter complex and ligand gated channel activity  in Gene Ontology (GO) were differentially enriched in the high SYT16 expression phenotype pathway. Neuroactive ligand receptor interaction, calcium signaling pathway, long term potentiation, type II diabetes mellitus and long term depression were identified as differentially enriched  pathway in Kyoto Encyclopedia of Genes and Genomes (KEGG).

CONCLUSION

SYT16 is a Prognostic Biomarker and Correlated with Immune Infiltrates in LGG.

摘要

背景

神经胶质瘤是最致命的原发性脑肿瘤。低级别神经胶质瘤(LGG)是神经胶质瘤的关键病理类型。肿瘤微环境中的免疫浸润与 LGG 的总生存期呈正相关。Syt16 是一种尚未在癌症中报道的基因。我们通过公共可用的 TCGA 数据库评估 Syt16 在 LGG 中的作用。

方法

使用基因表达谱分析交互分析(GEPIA)分析 Syt16 在 LGG 中的表达。我们通过生存模块评估 Syt16 对 LGG 患者生存的影响。然后,从 TCGA 下载 LGG 数据集。使用逻辑回归分析临床信息与 Syt16 表达的相关性。单变量生存和多变量 Cox 分析用于比较几种临床特征与生存的关系。我们还使用 CIBERSORT 和 GEPIA 的相关模块探索 Syt16 与癌症免疫浸润之间的相关性。使用 TCGA 数据集进行基因集富集分析(GSEA)。此外,我们使用 TIMER 探索 LGG 中 Syt16 表达和免疫浸润水平的集合,并探索 LGG 中的累积生存。

结果

使用逻辑回归的单变量分析表明,Syt16 表达增加与肿瘤分级显著相关。此外,多变量分析显示上调的 Syt16 表达是预后良好的独立预后因素。具体而言,Syt16 表达水平与 LGG 中 B 细胞、CD4+T 细胞、巨噬细胞、中性粒细胞和 DC 浸润水平呈显著负相关。此外,GSEA 确定了单一生物体行为、门控通道活性、认知、转运体复合物和配体门控通道活性在基因本体论(GO)中差异富集在高 Syt16 表达表型途径中。神经活性配体受体相互作用、钙信号通路、长时程增强、II 型糖尿病和长时程抑郁在京都基因与基因组百科全书(KEGG)中被确定为差异富集途径。

结论

Syt16 是 LGG 的预后生物标志物,与免疫浸润相关。

相似文献

1
SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.SYT16 是胶质母细胞瘤的预后生物标志物,并与免疫浸润相关:基于 TCGA 数据的研究。
Int Immunopharmacol. 2020 Jul;84:106490. doi: 10.1016/j.intimp.2020.106490. Epub 2020 Apr 11.
2
EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.EFNA1 是与低级别胶质瘤免疫浸润相关的潜在关键基因。
Medicine (Baltimore). 2021 Jun 4;100(22):e26188. doi: 10.1097/MD.0000000000026188.
3
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.TYROBP 表达升高预示低级别胶质瘤患者预后不良和肿瘤免疫浸润程度高。
BMC Cancer. 2021 Jun 23;21(1):723. doi: 10.1186/s12885-021-08456-6.
4
PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.PLEKHA4 是胶质母细胞瘤的预后生物标志物,并与免疫浸润相关。
Biomed Res Int. 2023 Jan 17;2023:4504474. doi: 10.1155/2023/4504474. eCollection 2023.
5
Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.胃动素原作为低级别胶质瘤的预后生物标志物:基于癌症基因组图谱数据的研究。
Biomed Res Int. 2022 Jul 7;2022:2309339. doi: 10.1155/2022/2309339. eCollection 2022.
6
Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.TTC21A 在肺腺癌中的高表达预示着良好的预后和高水平的免疫浸润。
Int Immunopharmacol. 2020 Jan;78:106077. doi: 10.1016/j.intimp.2019.106077. Epub 2019 Dec 5.
7
CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.CKS2(CDC28 蛋白激酶调节亚基 2)是低级别胶质瘤的预后生物标志物:基于生物信息学分析和免疫组织化学的研究。
Bioengineered. 2021 Dec;12(1):5996-6009. doi: 10.1080/21655979.2021.1972197.
8
Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.弥漫性低级别胶质瘤肿瘤微环境中免疫相关基因和免疫细胞浸润的特征。
J Cell Physiol. 2020 Oct;235(10):7321-7331. doi: 10.1002/jcp.29633. Epub 2020 Mar 11.
9
SCAMP4 is a novel prognostic marker and correlated with the tumor progression and immune infiltration in glioma.SCAMP4是一种新型的预后标志物,与胶质瘤的肿瘤进展和免疫浸润相关。
Int J Biochem Cell Biol. 2021 Oct;139:106054. doi: 10.1016/j.biocel.2021.106054. Epub 2021 Aug 12.
10
PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma.PTPRN作为低级别胶质瘤的预后生物标志物并与免疫浸润相关。
Brain Sci. 2022 Jun 10;12(6):763. doi: 10.3390/brainsci12060763.

引用本文的文献

1
Multifaceted function of B cells in tumorigenesis.B细胞在肿瘤发生中的多方面功能。
Front Med. 2025 Apr;19(2):297-317. doi: 10.1007/s11684-025-1127-5. Epub 2025 Mar 22.
2
Selenoprotein GPX3 is a novel prognostic indicator for stomach adenocarcinoma and brain low-grade gliomas: Evidence from an integrative pan-cancer analysis.硒蛋白GPX3是胃腺癌和脑低级别胶质瘤的一种新型预后指标:来自综合泛癌分析的证据。
Heliyon. 2024 Jun 1;10(11):e32271. doi: 10.1016/j.heliyon.2024.e32271. eCollection 2024 Jun 15.
3
WSCD2 Expression: Its Relevance to Tumor-Infiltrating Immune Cells and Glioma Prognosis.
WSCD2表达:其与肿瘤浸润免疫细胞及胶质瘤预后的相关性
Curr Med Chem. 2024 Feb 26. doi: 10.2174/0109298673282921240220101914.
4
HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy.HDAC6 抑制剂 ACY-1215 通过增强 STAT1 乙酰化来阻断 PD-L1 用于结直肠癌免疫治疗。
Cancer Immunol Immunother. 2024 Jan 17;73(1):7. doi: 10.1007/s00262-023-03624-y.
5
An immune signature to predict the prognosis of -wildtype glioma patients and guide immune checkpoint blockade therapy.一种免疫特征可预测野生型脑胶质瘤患者的预后并指导免疫检查点阻断治疗。
Aging (Albany NY). 2023 Oct 6;15(19):10453-10472. doi: 10.18632/aging.205088.
6
Integrative Identification by Hi-C Revealed Distinct Advanced Structural Variations in Lung Adenocarcinoma Tissue.基于Hi-C的整合鉴定揭示了肺腺癌组织中不同的高级结构变异。
Phenomics. 2023 Jun 15;3(4):390-407. doi: 10.1007/s43657-023-00103-3. eCollection 2023 Aug.
7
Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.基于免疫细胞浸润模式不良特征基因的胶质瘤患者优化风险分层策略。
J Cancer Res Clin Oncol. 2023 Nov;149(15):13855-13874. doi: 10.1007/s00432-023-05209-9. Epub 2023 Aug 3.
8
NABP2 as an oncogenic biomarker promotes hepatocellular carcinoma progression and metastasis.NABP2作为一种致癌生物标志物促进肝细胞癌的进展和转移。
Am J Transl Res. 2023 Jun 15;15(6):4203-4227. eCollection 2023.
9
DUSP10 is a novel immune-related biomarker connected with survival and cellular proliferation in lower-grade glioma.DUSP10 是一种新型免疫相关生物标志物,与低级别胶质瘤患者的生存和细胞增殖相关。
Aging (Albany NY). 2023 Jun 29;15(12):5673-5697. doi: 10.18632/aging.204821.
10
Identification and validation of novel signature associated with hepatocellular carcinoma prognosis using Single-cell and WGCNA analysis.基于单细胞测序和 WGCNA 分析鉴定与肝癌预后相关的新型标志物并验证。
Int J Med Sci. 2023 May 11;20(7):870-887. doi: 10.7150/ijms.79274. eCollection 2023.